For following the competition: what moved in each program, several studies read as one move.
- GW5282
- golidocitinib
- Conventional CHOP regimen
- + 3 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Lymphoma, T-Cell to watchlistEvery Monday by email · turn it off any timePro · free during the beta